# Sun Pharmaceutical Industries Limited - Inspection Records Source: https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited/286f1fa0-a9e6-4928-acc7-c3a4ef147b87 > Inspection records and compliance data for Sun Pharmaceutical Industries Limited in Mohali, None. Access full analysis and detailed observations. --- ## Details - Name: Sun Pharmaceutical Industries Limited - FEI Number: 3002807979 - City: Mohali - State: None - Country Name: India - Address Line 1: Unit 1 Plot A-41, Sez Industrial Area, Phase Viii A - Zip Code: None - Facility Type: Finished Dosage Pharmaceutical Manufacturer - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE ## Related Documents - [483 - Sun Pharmaceutical Industries Limited - 2022-08-12](https://www.keypedia.com/records/483/sun-pharmaceutical-industries-limited/074bde2f-5ad2-42a9-805b-a497f54eaaaa) — source: FDA, date: August 12, 2022 - [483 - Sun Pharmaceutical Industries Limited - 2022-08-12](https://www.keypedia.com/records/483/sun-pharmaceutical-industries-limited/586f3e16-ec32-4b99-9550-0213cbf2e92b) — source: FDA, date: August 12, 2022 - [FDA Inspection 1177459 - Sun Pharmaceutical Industries Limited - 2022-08-12](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-industries-limited/88a2745c-b214-453b-b024-def59e8e55f4) — classification: Official Action Indicated (OAI), source: FDA, date: August 12, 2022 - [483 - Sun Pharmaceutical Industries Limited - 2020-02-07](https://www.keypedia.com/records/483/sun-pharmaceutical-industries-limited/79501485-3d89-4a81-a5e5-74e78330b880) — source: FDA, date: February 7, 2020 - [FDA Inspection 1117962 - Sun Pharmaceutical Industries Limited - 2020-02-07](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-industries-limited/7232f5bc-d48e-4e1c-b8d1-2ff68909a78a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2020 - [FDA Inspection 1094000 - Sun Pharmaceutical Industries Limited - 2019-05-10](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-industries-limited/406de877-cd3c-4559-aec7-845481ef462c) — classification: No Action Indicated (NAI), source: FDA, date: May 10, 2019 - [FDA Inspection 1068079 - Sun Pharmaceutical Industries Limited - 2018-09-14](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-industries-limited/5e664994-d466-4f22-ad1d-ade71bafaf08) — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2018 - [483 - Sun Pharmaceutical Industries Limited - 2016-11-16](https://www.keypedia.com/records/483/sun-pharmaceutical-industries-limited/5893aee7-aee7-44e0-bb85-828da09c0439) — source: FDA, date: November 16, 2016 - [FDA Inspection 994372 - Sun Pharmaceutical Industries Limited - 2016-11-16](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-industries-limited/4b2bb5ce-2097-4b7d-adf8-cef01487ac7a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 16, 2016 - [FDA Inspection 812385 - Sun Pharmaceutical Industries Limited - 2012-12-12](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-industries-limited/7f455c1b-bac7-409b-9873-b553d60a3f45) — classification: Official Action Indicated (OAI), source: FDA, date: December 12, 2012 - [FDA Inspection 735588 - Sun Pharmaceutical Industries Limited - 2011-06-22](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-industries-limited/b8b8ee23-34fd-4c94-8870-545bbcdf5d20) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 22, 2011 ## Related Companies - [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/526fd1b4-90b1-4e91-b9f5-a3eab997ed60) - [Pharmaceutics International, Inc.](https://www.keypedia.com/companies/pharmaceutics-international-inc/38fdf7bd-a7f3-486e-b74d-13b87414922e) - [Fresenius Kabi USA, LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/f0c47fa1-3b76-4e6c-82dd-d703086bdfdc) - [Lilly del Caribe, Inc](https://www.keypedia.com/companies/lilly-del-caribe-inc/5091d4cf-a496-46ba-96aa-da9dbb686073) - [Valneva Scotland Ltd.](https://www.keypedia.com/companies/valneva-scotland-ltd/7e6970c2-c9dd-4c5d-9d35-725121b6e877) - [Pyramid Laboratories, Inc.](https://www.keypedia.com/companies/pyramid-laboratories-inc/28e777be-a530-400a-97c6-9780ede4fb33) - [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76) - [Bioreliance Ltd.](https://www.keypedia.com/companies/bioreliance-ltd/fec1a160-db6a-4ebc-9632-aa6e2996e17e) - [Nang Kuang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nang-kuang-pharmaceutical-co-ltd/bdb8b0bb-4a8d-4f50-a72d-e250626e2818) - [MSN Laboratories Private Limited (Formulations Division, Unit-II)](https://www.keypedia.com/companies/msn-laboratories-private-limited-formulations-division-unit-ii/44914049-4b84-4bac-abac-9af09a223eb8) ## Related Officers - [ Assistant Country Director (USFDA India Office Drug Program)](https://www.keypedia.com/people/daniel-j-roberts/1e1836ac-8bca-4236-a267-33ee0456440c) - [Senior Consultant](https://www.keypedia.com/people/steven-d-kehoe/a080151a-e2eb-436d-95b1-950bde664288) - [Consumer Safety Officer](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3) - [Philip F. Istafanos](https://www.keypedia.com/people/philip-f-istafanos/c2fcfe52-1070-4551-bffc-f8bcfad5b30b) - [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa) - [Regional Manager](https://www.keypedia.com/people/jonah-s-ufferfilge/6bcd2028-9aca-4704-bd7b-c835874fad9d)